Sundlöv, Anna http://orcid.org/0000-0003-1565-3496
Gustafsson, Johan
Brolin, Gustav
Mortensen, Nadja
Hermann, Rebecca
Bernhardt, Peter
Svensson, Johanna
Ljungberg, Michael
Tennvall, Jan
Sjögreen Gleisner, Katarina
Funding for this research was provided by:
Cancerfonden
Vetenskapsrådet (621-2014-6187)
Fru Berta Kamprads Stiftelse (2015-51, 2017-37)
Gunnar Nilssons Cancerstiftelse
Swedish Radiation Safety Authority
Stiftelsen Konung Gustaf V:s Jubileumsfond
Swedish Government ALF agreement
Article History
Received: 25 December 2017
Accepted: 21 March 2018
First Online: 5 July 2018
Authors’ information
: This trial, and the present analysis, has been made possible through the close collaboration between oncologists (AS, JS, JT), physicists (KSG, PB, ML, GB, JG) and specialized technologists (NM, RH).
: The trial has been approved by the institutional ethics committee (Regionala Etikprövningsnämden Lund, ref. no. 2011/287) and national regulatory authorities. All patients signed an informed consent before inclusion in the trial.
: Through the informed consent form, the patients agreed to have their data published in group form in an anonymized manner.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.